Primary Article

Cutaneous Leukocytoclastic Vasculitis: Clinical Experience in 44 Patients

Authors: JEFFREY P. CALLEN MD, EVA af EKENSTAM MD

Abstract

ABSTRACT: Chronic or recurrent cutaneous leukocytoclastic vasculitis is one of the more difficult therapeutic challenges to the practicing dermatologist. We have used a variety of therapeutic agents to treat 44 patients with leukocytoclastic vasculitis who had chronic or recurrent disease of more than three months duration. Sixteen cases were classified as urticarial vasculitis based on the major clinical manifestations, while the remaining 28 cases represented various patterns. Effectiveness of treatment was graded according to resolution of lesions, return to normal of abnormal laboratory findings, or the ability to lower the dosage of a second therapeutic agent (usually a corticosteroid). Systemic corticosteroids, azathioprine, and colchicine appeared to be effective in most patients. Nonsteroidal anti-inflammatory agents, sulfones, antihistamines, and antimalarials were effective only in sporadic cases. We present an approach to the treatment of this type of disorder.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References